Strande V, Hagen M, Lund C, Asak Ø, Bengtson MB, Boyar R, Detlie TE, Frigstad SO, Henriksen M, Holten KIA, Hovde Ø, Huppertz-Hauss G, Høie O, Johansen I, Medhus AW, Olsen BC, Opheim R, Perminow G, Ricanek P, Torp R, Valeur J, Vatn S, Aabrekk TB, Moum B, Høivik ML et al. (2025)
Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort
Scand J Gastroenterol, 1-12 (in press)
DOI 10.1080/00365521.2025.2512591, PubMed 40483585

Hansen SH, Maseng MG, Grännö O, Vestergaard MV, Bang C, Olsen BC, Lund C, Olbjørn C, Løvlund EE, Vikskjold FB, Huppertz-Hauss G, Perminow G, Yassin H, Valeur J, Aass Holten KI, Henriksen M, Bengtson MB, Ricanek P, Opheim R, Boyar R, Torp R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA et al. (2025)
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort
Inflamm Bowel Dis (in press)
DOI 10.1093/ibd/izaf060, PubMed 40285477

Pertsinidou E, Salomon B, Bergemalm D, Salihovic S, Hedin CRH, Ling Lundström M, Keita ÅV, Magnusson MK, Eriksson C, Bengtson MB, Grännö O, Aabrekk TB, Movérare R, Rydell N, Ekoff H, Rönnelid J, , D'Amato M, Detlie TE, Huppertz-Hauss G, Opheim R, Ricanek P, Kristensen VA, Öhman L, Söderholm JD et al. (2025)
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype
J Crohns Colitis, 19 (5)
DOI 10.1093/ecco-jcc/jjaf062, PubMed 40251889